AI assistant
Sending…
Zymeworks Inc. — Director's Dealing 2025
Aug 13, 2025
32180_dirs_2025-08-12_04df1265-29d2-432e-bf52-a47e9dd86775.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Zymeworks Inc. (ZYME)
CIK: 0001937653
Period of Report: 2025-08-11
Reporting Person: Ciongoli Gregory Austin (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-08-12 | Common Stock | A | 415000 | $12.02 | Acquired | 488500 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-08-11 | Stock Option (Right to Buy) | $12.44 | A | 62000 | Acquired | 2035-08-10 | Common Stock (62000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 5000 | Indirect |
Footnotes
F1: Represents shares held by 4 Arrows Holdings, LLC, for which the reporting person is the manager. The reporting person exercises sole voting and dispositive power over these shares and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F2: Stock options vest in 36 equal monthly installments starting one month after grant date of August 11, 2025.